Lung cancer cell-derived exosomes (LCCDEs) are pivotal in cancer development and show potential in diagnostics, therapeutics, and predicting outcomes. Their roles in cell proliferation, metastasis, angiogenesis, immune regulation, and drug resistance highlight their importance in liquid biopsy and targeted drug delivery, offering promise for lung cancer treatment.